US Stock MarketDetailed Quotes

Redhill Biopharma (RDHL)

Watchlist
  • 1.085
  • -0.005-0.46%
Close May 1 15:32 ET
  • 1.070
  • -0.015-1.38%
Post 20:01 ET
5.63MMarket Cap0.00P/E (TTM)

Redhill Biopharma (RDHL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(FY)Dec 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
286K
0
0
-90.21%1.8M
-72.54%3.6M
-27.94%61.8M
-42.01%12.8M
-18.77%17.55M
-14.68%18.35M
-36.31%13.1M
Operating revenue
--286K
--0
--0
-90.21%1.8M
-72.54%3.6M
-27.94%61.8M
-42.01%12.8M
-18.77%17.55M
-14.68%18.35M
-36.31%13.1M
Cost of revenue
-7.72%3.19M
-89.62%3.46M
-91.04%806K
-74.38%1.61M
-32.52%33.34M
-55.53%8.6M
2.41%9.45M
-15.06%9M
-38.62%6.29M
Gross profit
57.96%4.85M
-89.21%3.07M
-89.41%990K
-70.83%1.99M
-21.70%28.46M
53.45%4.2M
-34.56%8.1M
-14.31%9.35M
-34.01%6.81M
Operating expense
26.56%8.2M
-32.18%6.48M
-86.61%9.55M
161.43%48.39M
-215.58%-27.09M
-39.31%71.31M
-39.63%14.15M
-48.93%15.21M
-48.29%18.51M
-17.68%23.44M
Selling and administrative expenses
26.29%6.17M
-18.79%4.89M
-90.60%6.02M
-52.69%8.06M
-46.48%10.91M
-27.23%64.03M
-25.92%13.02M
-43.25%13.6M
-33.11%17.04M
-2.92%20.38M
-Selling and marketing expense
----
-52.17%1M
-76.87%2.1M
-51.23%4.52M
-59.32%5.11M
-20.44%9.06M
40.28%-19.87M
-54.31%7.09M
-39.13%9.27M
-9.61%12.56M
-General and administrative expense
26.29%6.17M
-18.79%4.89M
-89.05%6.02M
-54.44%3.54M
-25.85%5.8M
-28.24%54.97M
-35.32%32.88M
-22.90%6.5M
-24.13%7.77M
10.19%7.82M
Research and development costs
27.39%2.02M
-55.00%1.59M
-51.52%3.53M
-15.29%1.25M
-64.60%1.08M
-75.32%7.28M
-80.69%1.13M
-72.29%1.61M
-85.75%1.47M
-59.09%3.06M
Other operating expenses
----
----
----
----
---39.08M
----
----
----
----
----
Operating profit
-22.15%-7.91M
32.18%-6.48M
77.72%-9.55M
-417.53%-47.4M
274.88%29.08M
47.19%-42.84M
51.94%-9.95M
59.14%-7.11M
63.20%-9.16M
8.39%-16.63M
Net non-operating interest income expense
6.40%-1.33M
21.31%-1.42M
95.72%-1.81M
302.55%5.17M
642.73%21.16M
-154.55%-42.21M
-96.46%-7.16M
-616.80%-28.59M
39.74%-2.55M
17.24%-3.9M
Non-operating interest income
-70.89%23K
-13.19%79K
-35.00%91K
326.90%7.1M
215,720.00%21.58M
174.51%140K
-39,450.00%-4.72M
18,664.71%3.19M
10,980.00%1.66M
-76.19%10K
Non-operating interest expense
-56.82%19K
-30.16%44K
-99.85%63K
-54.30%1.93M
-89.23%421K
149.49%41.33M
-60.28%1.43M
693.38%31.78M
-0.85%4.21M
-17.76%3.91M
Total other finance cost
-8.37%1.34M
-20.60%1.46M
80.97%1.84M
----
----
1,460.00%1.01M
----
----
----
----
Other net income (expense)
-85.95%1.16M
215.60%8.26M
-153.38%-7.14M
47,892.86%13.38M
Gain on sale of security
-85.55%1.19M
245.27%8.26M
-142.47%-5.68M
----
----
47,892.86%13.38M
----
----
----
----
Earnings from equity interest
---33K
--0
--0
----
----
----
----
----
----
----
Special income (charges)
--0
--0
---1.46M
----
----
--0
----
----
----
----
-Less:Other special charges
----
61.69%2.36M
--1.46M
----
----
----
----
----
----
----
-Gain on sale of business
----
----
--35.5M
----
----
----
----
----
----
----
Other non- operating income (expenses)
----
----
--8.56M
----
----
----
----
----
----
----
Income before tax
-2,344.44%-8.08M
101.95%360K
74.19%-18.5M
106.50%761K
344.74%50.24M
26.68%-71.67M
84.70%-3.73M
-66.93%-35.7M
59.79%-11.71M
10.21%-20.53M
Income tax
Net income
94.81%-429K
-134.57%-8.27M
133.37%23.92M
106.50%761K
344.74%50.24M
26.68%-71.67M
84.70%-3.73M
-66.93%-35.7M
59.79%-11.71M
10.21%-20.53M
Net income continuous Operations
-2,344.44%-8.08M
101.95%360K
74.19%-18.5M
106.50%761K
344.74%50.24M
26.68%-71.67M
84.70%-3.73M
-66.93%-35.7M
59.79%-11.71M
10.21%-20.53M
Net income discontinuous operations
188.68%7.65M
-120.34%-8.63M
--42.41M
----
----
----
----
----
----
----
Minority interest income
Net income attributable to the parent company
94.81%-429K
-134.57%-8.27M
133.37%23.92M
106.50%761K
344.74%50.24M
26.68%-71.67M
84.70%-3.73M
-66.93%-35.7M
59.79%-11.71M
10.21%-20.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
94.81%-429K
-134.57%-8.27M
133.37%23.92M
106.50%761K
344.74%50.24M
26.68%-71.67M
84.70%-3.73M
-66.93%-35.7M
59.79%-11.71M
10.21%-20.53M
Basic earnings per share
0
0
108.33%100
102.41%4.8263
225.00%500
42.86%-1.2K
0
-20.00%-600
66.67%-200
20.00%-400
Diluted earnings per share
0
0
108.33%100
102.41%4.8263
225.00%500
42.86%-1.2K
0
-20.00%-600
66.67%-200
20.00%-400
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(FY)Dec 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 286K00-90.21%1.8M-72.54%3.6M-27.94%61.8M-42.01%12.8M-18.77%17.55M-14.68%18.35M-36.31%13.1M
Operating revenue --286K--0--0-90.21%1.8M-72.54%3.6M-27.94%61.8M-42.01%12.8M-18.77%17.55M-14.68%18.35M-36.31%13.1M
Cost of revenue -7.72%3.19M-89.62%3.46M-91.04%806K-74.38%1.61M-32.52%33.34M-55.53%8.6M2.41%9.45M-15.06%9M-38.62%6.29M
Gross profit 57.96%4.85M-89.21%3.07M-89.41%990K-70.83%1.99M-21.70%28.46M53.45%4.2M-34.56%8.1M-14.31%9.35M-34.01%6.81M
Operating expense 26.56%8.2M-32.18%6.48M-86.61%9.55M161.43%48.39M-215.58%-27.09M-39.31%71.31M-39.63%14.15M-48.93%15.21M-48.29%18.51M-17.68%23.44M
Selling and administrative expenses 26.29%6.17M-18.79%4.89M-90.60%6.02M-52.69%8.06M-46.48%10.91M-27.23%64.03M-25.92%13.02M-43.25%13.6M-33.11%17.04M-2.92%20.38M
-Selling and marketing expense -----52.17%1M-76.87%2.1M-51.23%4.52M-59.32%5.11M-20.44%9.06M40.28%-19.87M-54.31%7.09M-39.13%9.27M-9.61%12.56M
-General and administrative expense 26.29%6.17M-18.79%4.89M-89.05%6.02M-54.44%3.54M-25.85%5.8M-28.24%54.97M-35.32%32.88M-22.90%6.5M-24.13%7.77M10.19%7.82M
Research and development costs 27.39%2.02M-55.00%1.59M-51.52%3.53M-15.29%1.25M-64.60%1.08M-75.32%7.28M-80.69%1.13M-72.29%1.61M-85.75%1.47M-59.09%3.06M
Other operating expenses -------------------39.08M--------------------
Operating profit -22.15%-7.91M32.18%-6.48M77.72%-9.55M-417.53%-47.4M274.88%29.08M47.19%-42.84M51.94%-9.95M59.14%-7.11M63.20%-9.16M8.39%-16.63M
Net non-operating interest income expense 6.40%-1.33M21.31%-1.42M95.72%-1.81M302.55%5.17M642.73%21.16M-154.55%-42.21M-96.46%-7.16M-616.80%-28.59M39.74%-2.55M17.24%-3.9M
Non-operating interest income -70.89%23K-13.19%79K-35.00%91K326.90%7.1M215,720.00%21.58M174.51%140K-39,450.00%-4.72M18,664.71%3.19M10,980.00%1.66M-76.19%10K
Non-operating interest expense -56.82%19K-30.16%44K-99.85%63K-54.30%1.93M-89.23%421K149.49%41.33M-60.28%1.43M693.38%31.78M-0.85%4.21M-17.76%3.91M
Total other finance cost -8.37%1.34M-20.60%1.46M80.97%1.84M--------1,460.00%1.01M----------------
Other net income (expense) -85.95%1.16M215.60%8.26M-153.38%-7.14M47,892.86%13.38M
Gain on sale of security -85.55%1.19M245.27%8.26M-142.47%-5.68M--------47,892.86%13.38M----------------
Earnings from equity interest ---33K--0--0----------------------------
Special income (charges) --0--0---1.46M----------0----------------
-Less:Other special charges ----61.69%2.36M--1.46M----------------------------
-Gain on sale of business ----------35.5M----------------------------
Other non- operating income (expenses) ----------8.56M----------------------------
Income before tax -2,344.44%-8.08M101.95%360K74.19%-18.5M106.50%761K344.74%50.24M26.68%-71.67M84.70%-3.73M-66.93%-35.7M59.79%-11.71M10.21%-20.53M
Income tax
Net income 94.81%-429K-134.57%-8.27M133.37%23.92M106.50%761K344.74%50.24M26.68%-71.67M84.70%-3.73M-66.93%-35.7M59.79%-11.71M10.21%-20.53M
Net income continuous Operations -2,344.44%-8.08M101.95%360K74.19%-18.5M106.50%761K344.74%50.24M26.68%-71.67M84.70%-3.73M-66.93%-35.7M59.79%-11.71M10.21%-20.53M
Net income discontinuous operations 188.68%7.65M-120.34%-8.63M--42.41M----------------------------
Minority interest income
Net income attributable to the parent company 94.81%-429K-134.57%-8.27M133.37%23.92M106.50%761K344.74%50.24M26.68%-71.67M84.70%-3.73M-66.93%-35.7M59.79%-11.71M10.21%-20.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 94.81%-429K-134.57%-8.27M133.37%23.92M106.50%761K344.74%50.24M26.68%-71.67M84.70%-3.73M-66.93%-35.7M59.79%-11.71M10.21%-20.53M
Basic earnings per share 00108.33%100102.41%4.8263225.00%50042.86%-1.2K0-20.00%-60066.67%-20020.00%-400
Diluted earnings per share 00108.33%100102.41%4.8263225.00%50042.86%-1.2K0-20.00%-60066.67%-20020.00%-400
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More